Please login to the form below

Not currently logged in
Email:
Password:

Dezima Pharma

This page shows the latest Dezima Pharma news and features for those working in and with pharma, biotech and healthcare.

Amgen takes aim at cardio diseases with Arrowhead RNAi deal

Amgen takes aim at cardio diseases with Arrowhead RNAi deal

This is not the first time it has bought in drugs to flesh out its cardiovascular R&D portfolio - last year it acquired Dezima Pharma in a deal valued at up

Latest news

  • Merck seeks oasis in CETP inhibitor desert Merck seeks oasis in CETP inhibitor desert

    Amgen recently bought its way into the category via the acquisition of Dezima Pharma, which included a CETP inhibitor - TA-8995 - that has shown promise in a phase II trial and

  • Amgen boosts pipeline with two deals topping $3bn Amgen boosts pipeline with two deals topping $3bn

    Amgen has agreed to buy Dezima Pharma to add a new drug to its cardiovascular pipeline, and forged a broad collaboration with Xencor in oncology and inflammation. ... Dezima licensed TA-8995 from Mitsubishi Tanabe Pharma, which will claim a share of Amgen

More from news
Approximately 2 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Enterprise Therapeutics appoints CEO Enterprise Therapeutics appoints CEO

    Dr Ford also brings experience from Ario Pharma, where he is currently chief executive officer and co-founder, and Metrion Biosciences, where he serves as co-owner and investor director. ... Previously, Dr Ford has worked as general manager of Akarna

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics